MedTrace Logo

Transradial Evaluation Study of Diameter Increase After Vasodilatory Drugs Administration.

NCT04317846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2024-08-06

No results posted yet for this study

Summary

Radial artery access use in percutaneous cardiac interventions (PCI) is associated with a lower risk of vascular complications, bleeding and major adverse cardiac events including cardiac death in the long-term follow-up. Intra-radial administration of vasodilatory drugs, transiently painful for the patient, reduces the risk of spasm and is currently the standard technique performed worldwide. However, the efficacy of intravenous administration of vasodilatory drugs has never been evaluated.

Conditions

Interventions

OTHER

Intravenous administration of vasodilatory drugs

Administration of the vasodilatory drugs in a different pattern than intra-arterially

Sponsors & Collaborators

  • Centre de recherche clinique - FBM-CHUV

    collaborator UNKNOWN

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Vladimir Rubimbura, MD · MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-22
Primary Completion
2024-02-13
Completion
2024-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04317846 on ClinicalTrials.gov